BYRD, Kenneth; TRUONG, Phu. Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance. Kansas Journal of Medicine, [S. l.], v. 7, n. 4, p. 167–170, 2014. DOI: 10.17161/kjm.v7i4.11507. Disponível em: https://journals.ku.edu/kjm/article/view/11507. Acesso em: 18 apr. 2025.